| Retail Food Group Limited (RFG) ORDINARY FULLY PAID |
Consumer Discretionary |
$51 |
New NED Appointments & Extension of Chairman's Employment
|
25 Feb 2026 1:15PM |
$1.090 |
$0.810 |
fallen by
25.69%
|
|
| Carnegie Clean Energy Limited (CCE) ORDINARY FULLY PAID |
Utilities |
$84 |
Half Yearly Report and Accounts
|
25 Feb 2026 1:15PM |
$0.059 |
$0.205 |
risen by
247.46%
|
|
CCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax for the period was $1,705,035.
- Sales revenue for the half-year increased by 45.4% to $237,708.
- Carnegie's principal activities included the development of CETO technology and MoorPower.
- Product development supported by the ACHIEVE Programme and international collaborations.
- Shares issued to improve capital and cash position.
- Garden Island Microgrid contributed significantly to revenue.
- Engagement in several funded project contracts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Vintage Ltd (AVG) ORDINARY FULLY PAID |
Consumer Staple |
$20 |
Change of Director's Interest Notice - James Williamson
|
25 Feb 2026 1:13PM |
$0.086 |
$0.062 |
fallen by
27.91%
|
|
| Australian Finance Group Ltd (AFG) ORDINARY FULLY PAID |
Financials |
$466 |
Ceasing to be a substantial holder from CBA
|
25 Feb 2026 1:09PM |
$1.835 |
$1.715 |
fallen by
6.54%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$271,486 |
Ceasing to be a substantial holder for AFG
|
25 Feb 2026 1:09PM |
$179.765 |
$162.230 |
fallen by
9.75%
|
|
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$81 |
Dividend/Distribution - ACQ
|
25 Feb 2026 1:07PM |
$0.980 |
$0.900 |
fallen by
8.16%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$3,213 |
Court approves Scheme Meeting & Scheme Booklet distribution
|
25 Feb 2026 1:07PM |
$4.675 |
$4.790 |
risen by
2.46%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- Federal Court of Australia approved the Scheme Meeting and distribution of Scheme Booklet.
- Proposed acquisition by Daintree BidCo Pty Ltd via scheme of arrangement.
- Scheme Meeting scheduled for 13 April 2026.
- Scheme Booklet to be dispatched by 4 March 2026.
- Independent Expert’s Report concludes the Scheme is fair and reasonable.
- Insignia Financial Board recommends shareholders vote in favor of the Scheme.
- Scheme Consideration of $4.80 per share is within the assessed value range.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$81 |
Half Year Accounts - Appendix 4D
|
25 Feb 2026 1:06PM |
$0.980 |
$0.900 |
fallen by
8.16%
|
|
ACQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $22.921 million, up 306% from the previous year.
- Profit before tax rose to $22.042 million, a 366% increase.
- Profit after tax attributable to members was $15.419 million, a 359% increase.
- Declared interim dividend of 3.50 cents per share, fully franked at 30%.
- Dividend reinvestment plan (DRP) will apply to this and future dividends.
- Net tangible asset backing per share post-tax was $1.2533.
- Financial report reviewed by Ernst & Young for compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4D & Half Year Report 31 December 2025
|
25 Feb 2026 1:04PM |
$0.010 |
$0.011 |
risen by
10%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities decreased by 66% to $177,564.
- Net loss after tax decreased by 56% to $514,975.
- The Anti-Obesity Project's compound AOC showed significant activity in pre-clinical studies.
- Delays in Mechanism of Action studies due to international unavailability of a testing kit.
- Successful GaRP-IBS Phase II trial completion.
- Completed a capital raising of A$1.2 million.
- Focused on unmet medical needs in gastrointestinal health.
- Cash at the end of the half year was $1.085 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$176 |
Stealth 1H FY26 Briefing Presentation
|
25 Feb 2026 1:02PM |
$1.280 |
$1.180 |
fallen by
7.81%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record sales of $82.2 million, an 11.8% increase.
- Acquisition of Hardware & Building Traders (HBT) strengthens market position.
- Increased EBITDA of $5.4 million and net profit after tax of $1.6 million.
- Cash balance increased by 212.5% to $32.5 million.
- Focus on leveraging national distribution platform and procurement scale.
- Strong balance sheet with low net debt for future investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPM Minerals Limited (BPM) ORDINARY FULLY PAID |
Materials |
$23 |
Notice of General Meeting/Proxy Form
|
25 Feb 2026 1:01PM |
$0.335 |
$0.180 |
fallen by
46.27%
|
|
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$176 |
Stealth delivers record half year result
|
25 Feb 2026 1:01PM |
$1.280 |
$1.180 |
fallen by
7.81%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record half-year financial performance with $82.2 million in gross sales.
- Revenue increased to $72.0 million, with EBITDA rising by 18.8%.
- NPAT increased by 51.4%, reaching $1.6 million.
- Acquisition of Hardware & Building Traders (HBT) added 1,165 independent stores.
- Stealth aims for $500 million+ sales by FY28 with a capital-light model.
- Focus on procurement leverage, exclusive brands, and operational efficiency.
- Strengthened balance sheet with a $19.5 million capital raise.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$176 |
Half Yearly Report and Accounts
|
25 Feb 2026 1:00PM |
$1.280 |
$1.180 |
fallen by
7.81%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Stealth Group Holdings Ltd reported record half-year sales of $82.2 million, an increase of 11.8% from the previous year.
- The company achieved revenue of $72.0 million, up 0.7% from the prior period, and maintained its gross profit margin.
- The underlying EBITDA increased by 17.5% to $5.4 million.
- Net Profit After Tax (NPAT) rose by 1.56% to $1.6 million.
- Operating cash inflow was $1.6 million, with net assets amounting to $49.5 million as of 31 December 2025.
- Stealth Group Holdings completed a $19.5 million capital raising and acquired Hardware & Building Traders Pty Limited.
- The company increased its net assets by $19.3 million from 30 June 2025.
- Intangible assets grew significantly due to acquisitions, with goodwill from acquisitions reaching $42.96 million.
- The balance sheet and cash flows are reported to have strengthened, supporting future growth and transformation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$40 |
Imugene Receives $2.7M R&D Tax Refund
|
25 Feb 2026 12:52PM |
$0.250 |
$0.095 |
fallen by
62%
|
|
| Australian Bond Exchange Holdings Limited (ABE) ORDINARY FULLY PAID |
Financials |
$2 |
Update - Proposed issue of securities - ABE
|
25 Feb 2026 12:41PM |
$0.031 |
$0.011 |
fallen by
64.52%
|
|
| Anax Metals Limited (ANX) ORDINARY FULLY PAID |
Materials |
$56 |
Anax Metals Limited Investor Webinar
|
25 Feb 2026 12:41PM |
$0.034 |
$0.032 |
fallen by
5.88%
|
|
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$557 |
Appendix 4D and Half Year Report 31 December 2025
|
25 Feb 2026 12:41PM |
$2.010 |
$1.990 |
fallen by
1%
|
|
| Claremont Global Fund (Hedged) (Managed Fund) (CGHE) CLAREMONT GLOBAL FUND (HEDGED) ACTIVE ETF |
Financials |
$41 |
Quarterly Portfolio Disclosure - December 2025
|
25 Feb 2026 12:37PM |
$1.615 |
$1.520 |
fallen by
5.88%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$40 |
Half Yearly Report and Accounts
|
25 Feb 2026 12:37PM |
$0.250 |
$0.095 |
fallen by
62%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited reported a loss of $37,820,158 for the half-year ended 31 December 2025.
- The reduction in loss compared to the previous year was mainly due to decreased personnel-related expenses and clinical trial costs.
- Cash reserves as of 31 December 2025 were $14,136,296.
- Azer-cel Phase 1b trial achieved 82% overall response rate in relapsed/refractory DLBCL patients.
- A new collaboration with JW Therapeutics was established to advance the onCARlytics program.
- Operating costs are expected to be approximately 50% lower than the prior financial year.
- The company completed a $22.5 million institutional placement and a $2.42 million Share Purchase Plan.
- Convertible notes were amended for improved cash flow management.
- The company focuses on advancing the azer-cel program, while onCARlytics is expected to benefit from reduced capital expenditure through collaboration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$793 |
Daily Net Tangible Asset Statement
|
25 Feb 2026 12:35PM |
$1.085 |
$1.085 |
fallen by
0%
|
|
| Claremont Global Fund (Managed Fund) (CGUN) CLAREMONT GLOBAL FUND ACTIVE ETF |
Financials |
$50 |
Quarterly Portfolio Disclosure - December 2025
|
25 Feb 2026 12:34PM |
$1.400 |
$1.330 |
fallen by
5%
|
|
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$223 |
Change in substantial holding
|
25 Feb 2026 12:31PM |
$0.170 |
$0.225 |
risen by
32.35%
|
|
| Caravel Minerals Limited (CVV) ORDINARY FULLY PAID |
Materials |
$162 |
Project Update - Caravel Copper Project
|
25 Feb 2026 12:30PM |
$0.410 |
$0.290 |
fallen by
29.27%
|
|
CVV - Price-sensitive ASX Announcement
Full Release
Key Points
- DFS on track for June 2026 release; regulatory approvals targeted end 2027.
- Technical and feasibility studies are progressing to plan.
- Strategic partnership with Adani is advancing positively.
- Additional water investigations underway to meet regulatory requirements.
- EPA assessments are on schedule for Ministerial approval end 2027.
- Company is mitigating impact with parallel advancement of engineering, financing, and stakeholder workstreams.
- Commitment to high ESG standards is critical for Export Credit Agency-backed financing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$10,750 |
LNW - Receipt of Listing Rule Waiver
|
25 Feb 2026 12:26PM |
$141.740 |
$131.010 |
fallen by
7.57%
|
|
| Duratec Limited (DUR) ORDINARY FULLY PAID |
Industrials |
$749 |
Dividend/Distribution - DUR
|
25 Feb 2026 12:25PM |
$2.110 |
$2.900 |
risen by
37.44%
|
|